Esketamine Hydrochloride and Insulin Glargine (U-300) Pens
Determining the interaction of Esketamine Hydrochloride and Insulin Glargine (U-300) Pens and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: esketamine
Brand name: Spravato
Synonyms: Esketamine (nasal), Esketamine
Generic Name: insulin glargine
Brand name: Basaglar KwikPen, Lantus, Lantus Solostar Pen, Toujeo SoloStar, Lantus OptiClik Cartridge, Toujeo Max SoloStar, Lantus SoloStar
Synonyms: Insulin glargine, Insulin Glargine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Esketamine Hydrochloride-Insulin glargine and lixisenatide
- Esketamine Hydrochloride-Insulin glargine and lixisenatide Subcutaneous
- Esketamine Hydrochloride-Insulin glargine, recombinant Subcutaneous
- Esketamine Hydrochloride-Insulin glulisine
- Esketamine Hydrochloride-Insulin Glulisine (Cartridges and Pens)
- Esketamine Hydrochloride-Insulin Glulisine (Vials)
- Insulin Glargine (U-300) Pens-Esketamine nasal
- Insulin Glargine (U-300) Pens-Eslicarbazepine
- Insulin Glargine (U-300) Pens-Eslicarbazepine Acetate
- Insulin Glargine (U-300) Pens-Esmolol
- Insulin Glargine (U-300) Pens-Esmolol HCl
- Insulin Glargine (U-300) Pens-Esmolol Hydrochloride